A £100,000 Wellcome Trust Seed Award has been granted to fund a project using fruit flies (Drosophila) to examine an important yet poorly understood aspect of human heart physiology.
The heart senses and adapts to its own highly dynamic mechanical environment. This environment changes beat-by-beat, as well as over longer timescales, due to altered physiology or as a consequence of disease. Failure to detect and adjust cardiac performance accordingly is associated with arrhythmias and sudden cardiac death. The mechanism for this adaptation is not known.
The goal is to study the cellular and molecular basis of this mechanism using the Drosophila heart as a simple model. Preliminary data obtained for an Honours project suggests that stretch-activated mechanosensitive ion channels are key components.
Research supported by Paul Hartley’s lab here at Bournemouth University and led by Dr Barry Denholm (University of Edinburgh) will investigate the hypothesis that these channels provide a direct link to convert physical force (stretch of the cardiac tissue) into biochemical signal (ion flux), which in turn regulates heart physiology and function (contractility).












SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Innovative Approaches to Doctoral Supervision: Selected Case Studies
3C Event: Research Culture, Community & Canapés-Tuesday 19 May 1-2pm
New chapters published in maternity book on risk
The British Academy European Research Council Grant Support Sessions
Grant Writing Workshops: Master the Art of the Winning Proposal
Apply now to take part in the 2026 ESRC Festival of Social Science
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease